CME vs SPGI vs VRSK Stock Comparison

Cme, S&P Global and Verisk Analytics Prices as of Nov 13, 2026 Peers: Industry group
CME Cme Group Inc.
$317.97 +11.3% 1M +12.1% 1Y
Market cap
$114.18B
P/E
25.9x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
7 wins
SPGI S&P Global Inc.
$473.60 +15.9% 1M -5.8% 1Y
Market cap
$137.07B
P/E
27.5x
Revenue (TTM)
$17.21B
Div. yield
0.01%
Financial Data and Analytics Financial Services
3 wins
VRSK Verisk Analytics, Inc.
$207.82 +15.1% 1M -4.5% 1Y
Market cap
$27.51B
P/E
31.3x
Revenue (TTM)
$3.18B
Div. yield
–
Financial Data and Analytics Financial Services
1 win

Head to Head

11 decided of 12

Cme leads on 7 of the 12 questions below (Cme 7, S&P Global 3, Verisk Analytics 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCMESPGIVRSKLeader
Larger companyMarket capitalisation $114.18B $137.07B $27.51B SPGI
Cheaper on earningsLower P/E, profitable companies only 25.9x 27.5x 31.3x CME
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.1x 25.0x 26.1x SPGI
Faster revenue growthRevenue growth, trailing twelve months +9.0% +18.2% +4.9% SPGI
More profitableNet margin, trailing twelve months 63.3% 29.0% 27.7% CME
Better return on capitalReturn on invested capital 11.7% 14.9% 31.9% VRSK
Less leveragedLower net debt / EBITDA 0.2x 1.2x 2.3x CME
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months +12.1% -5.8% -4.5% CME
Better 5-year returnAnnualised price return, 5 years +7.2%/yr +0.9%/yr -0.8%/yr CME
Less volatileAnnualised volatility, 1 year 25.5% 30.6% 36.4% CME
Higher overall scoreMean of the five percentile scores vs peers 63/100 61/100 54/100 CME

Percentile Scorecard

CMESPGIVRSK

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCMESPGIVRSK
Valuation 53 #63 of 134 32 #751 of 1108 37 #699 of 1108
Growth 30 #59 of 84 75 #229 of 897 40 #540 of 897
Profitability 87 #12 of 88 91 #80 of 922 95 #46 of 922
Financial Health 51 #75 of 151 57 #468 of 1098 27 #798 of 1098
Shareholder Returns 92 #5 of 49 48 #397 of 758 70 #230 of 758
Overall 63 61 54
  • CME ranked among 158 companies in Capital Markets
  • SPGI ranked among 1,197 companies in Financial Services
  • VRSK ranked among 1,197 companies in Financial Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCMESPGIVRSKSPY
1 month +11.3%+15.9%+15.1% -2.0%
3 months +17.9%+13.1%+14.4% -2.8%
6 months +6.4%+17.5%+27.8% +2.0%
Year to date +16.4%-9.4%-7.1% +10.6%
1 year +12.1%-5.8%-4.5% +12.2%
3 years +50.2%+17.3%-12.7% +68.1%
3 years, per year +14.5%+5.5%-4.4% +18.9%
5 years +41.4%+4.5%-3.9% +61.4%
5 years, per year +7.2%+0.9%-0.8% +10.1%
10 years +178.0%+277.5%+150.0% +248.5%
10 years, per year +10.8%+14.2%+9.6% +13.3%

Risk

MeasureCMESPGIVRSKSPY
Volatility, 1Y 25.5%30.6%36.4% 13.6%
Downside volatility, 1Y 27.2%35.5%36.8% 13.9%
Beta vs S&P 500, 1Y -0.300.37-0.58 1.00
Return / volatility, 1Y 0.48-0.19-0.12 0.90
Max drawdown, 5Y -33.1%-40.2%-51.2% -25.4%
From 52-week high -2.6%-13.3%-7.7% -3.2%
52-week high $326.46$546.35$225.07 $779.14
52-week low $218.58$386.35$156.84 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCMESPGIVRSK
P/E now vs peer median 25.8xmedian 42.3x 27.7xmedian 14.9x 30.5xmedian 14.9x
P/S now vs peer median 16.3xmedian 3.9x 8.0xmedian 3.2x 8.4xmedian 3.2x
EV/EBITDA now vs peer median 23.4xmedian 12.7x 16.2xmedian 6.3x 17.5xmedian 6.3x
P/FCF now vs peer median 26.2xmedian 16.5x 23.5xmedian 10.5x 24.2xmedian 10.5x
P/B now vs peer median 4.3xmedian 3.7x 6.9xmedian 1.3x -23.9xmedian 1.3x
PEG now vs peer median 1.88median 0.52 0.93median 0.89 1.20median 0.89

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCMESPGIVRSK
Revenue $6.97B $17.21B $3.18B
Gross profit $1.37B $12.21B $2.23B
Operating income $4.58B $7.77B $1.39B
Net income $4.42B $5.40B $879.20M
Free cash flow $4.33B $5.84B $1.10B
EPS (diluted) $12.31 $17.10 $6.80
Cash & equivalents $2.20B $2.44B $556.80M
Total debt $3.43B $13.06B $4.50B
Shares (diluted) 358.64M 291.60M 129.23M
Enterprise value $102.52B $126.93B $23.69B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCMESPGIVRSK
P/E 25.8x 27.7x 30.5x
P/FCF 26.2x 23.5x 24.2x
P/Operating cash flow 25.7x 22.9x 19.5x
P/S 16.3x 8.0x 8.4x
P/B 4.3x 6.9x -23.9x
P/Tangible book 4.7x 17.4x -18.8x
EV/EBITDA 23.4x 16.2x 17.5x
EV/EBIT 25.1x 19.0x 21.9x
EV/Revenue 16.5x 8.6x 9.6x
EV/FCF 26.5x 25.3x 27.8x
EV/Operating cash flow 25.9x 24.7x 22.4x
PEG (3Y EPS CAGR) 1.88 0.93 1.20

Growth

14 metrics
MetricCMESPGIVRSK
Revenue growth (1Y) 9.0% 18.2% 4.9%
Revenue CAGR (3Y) 9.2% 11.9% 6.4%
Gross profit growth (1Y) 13.2% 19.7% 5.7%
Gross profit CAGR (3Y) 12.5% 14.4% 7.8%
Operating income growth (1Y) 10.1% 29.7% 3.6%
Operating income CAGR (3Y) 12.2% 26.4% 6.2%
Net income growth (1Y) 17.3% 18.3% -4.6%
Net income CAGR (3Y) 13.1% 25.3% 20.6%
EPS growth (1Y) 19.4% 23.4% 3.3%
EPS CAGR (3Y) 13.7% 29.9% 25.5%
Operating cash flow growth (1Y) 6.4% 18.5% 1.4%
Operating cash flow CAGR (3Y) 9.3% 19.8% 8.9%
Free cash flow growth (1Y) 6.1% 19.4% -1.4%
Free cash flow CAGR (3Y) 9.4% 20.2% 11.0%

Profitability

14 metrics
MetricCMESPGIVRSK
Gross margin 19.7% 70.9% 70.2%
EBITDA margin 70.4% 53.1% 55.0%
Operating margin 65.7% 45.1% 43.9%
Pretax margin 82.8% 43.4% 36.3%
Net margin 63.3% 29.0% 27.7%
FCF margin 62.1% 33.9% 34.6%
Operating cash flow margin 63.5% 34.8% 43.0%
Return on equity 16.6% 21.0% –
Return on assets 2.3% 9.7% 19.5%
Return on invested capital 11.7% 14.9% 31.9%
Return on capital employed 12.3% 16.6% 40.5%
Asset turnover 0.0x 0.3x 0.7x
Cash conversion (OCF / net income) 1.0x 1.1x 1.6x
Stock comp / revenue 1.4% 1.2% 1.9%

Financial Health

11 metrics
MetricCMESPGIVRSK
Debt / assets 1.8% 27.2% 99.0%
Debt / equity 0.1x 0.7x -4.0x
Net debt / EBITDA 0.2x 1.2x 2.3x
Debt / FCF 0.8x 2.2x 4.1x
Liabilities / assets 86.2% 58.7% 124.5%
Equity / assets 13.8% 41.3% -24.5%
Interest coverage 26.2x 24.0x 6.8x
Current ratio 1.0x 0.7x 1.1x
Quick ratio 0.0x 0.6x 0.9x
Cash ratio 0.0x 0.3x 0.5x
Altman Z-score 0.59 4.24 7.12

Shareholder Returns

7 metrics
MetricCMESPGIVRSK
Dividend yield 3.1% 0.8% 0.9%
Net buyback yield – 4.8% 7.0%
Shareholder yield 3.1% 5.6% 7.9%
Payout ratio (earnings) – 21.2% –
Payout ratio (FCF) – 19.6% –
Dividend growth (1Y) – -1.2% –
Dividend CAGR (3Y) – 0.2% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCMESPGIVRSK
Forward P/E 27.1xFY2026 25.0xFY2026 26.1xFY2026
EPS, next fiscal year $11.75FY2026 $18.93FY2026 $7.96FY2026
EPS growth, next FY +4.9%FY2026 +12.3%FY2026 +11.2%FY2026
EPS growth, the year after +19.3% +12.6% +5.3%
Revenue, next fiscal year $7.27BFY2026 $15.54BFY2026 $3.33BFY2026
Revenue growth, next FY +11.6%FY2026 +1.3%FY2026 +8.6%FY2026
Revenue growth, the year after +7.0% +6.6% +6.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCMESPGIVRSK
Held by institutions 88.9% 87.5% 97.6%
Institutions holding 1,694 2,004 956
Change in shares held, QoQ +0.4% +1.6% -0.4%
Institutions buying 824 873 489
Institutions selling 656 877 350
Buyers to sellers 1.26 1.00 1.40

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CMESPGIVRSK
CME 1.00 0.22 0.23
SPGI 0.22 1.00 0.58
VRSK 0.23 0.58 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CME, SPGI and VRSK?

S&P Global (SPGI) is the largest by market capitalisation: Cme (CME) $114.18B, S&P Global (SPGI) $137.07B, Verisk Analytics (VRSK) $27.51B.

Which stock is cheaper, CME, SPGI and VRSK?

Cme (CME) trades on the lowest price-to-earnings ratio (Cme (CME) 25.9x, S&P Global (SPGI) 27.5x, Verisk Analytics (VRSK) 31.3x). On next year's consensus earnings, S&P Global (SPGI) is cheapest (Cme (CME) 27.1x, S&P Global (SPGI) 25.0x, Verisk Analytics (VRSK) 26.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

S&P Global (SPGI) grew revenue fastest over the trailing twelve months: Cme (CME) +9.0%, S&P Global (SPGI) +18.2%, Verisk Analytics (VRSK) +4.9%.

Which company is more profitable?

Cme (CME) has the highest net margin (Cme (CME) 63.3%, S&P Global (SPGI) 29.0%, Verisk Analytics (VRSK) 27.7%). On return on invested capital, Verisk Analytics (VRSK) leads (Cme (CME) 11.7%, S&P Global (SPGI) 14.9%, Verisk Analytics (VRSK) 31.9%).

Which stock has performed better?

Over the past year Cme (CME) returned the most: Cme (CME) +12.1%, S&P Global (SPGI) -5.8%, Verisk Analytics (VRSK) -4.5%. Over five years, Cme (CME) compounded fastest (Cme (CME) +7.2%/yr, S&P Global (SPGI) +0.9%/yr, Verisk Analytics (VRSK) -0.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cme (CME) 0.00%, S&P Global (SPGI) 0.01%, Verisk Analytics (VRSK) 0.00%. Cme (CME) and Verisk Analytics (VRSK) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cme (CME) has been the steadiest (Cme (CME) 25.5%, S&P Global (SPGI) 30.6%, Verisk Analytics (VRSK) 36.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CME, SPGI and VRSK?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cme (CME) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.